Syndromic Medullary Thyroid Cancer: MEN 2A and MEN 2B

[1]  K. Lorenz,et al.  Genotype‐specific progression of hereditary medullary thyroid cancer , 2018, Human mutation.

[2]  P. Vestergaard,et al.  Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960–2014: a nationwide study , 2018, Endocrine connections.

[3]  K. Lorenz,et al.  Long‐term outcome of prophylactic thyroidectomy in children carrying RET germline mutations , 2018, The British journal of surgery.

[4]  S. Wells.  Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors. , 2017, Endocrine-related cancer.

[5]  T. Bruckner,et al.  Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon‐specific penetrance and changes in management during the last four decades , 2017, Clinical endocrinology.

[6]  A. Maia,et al.  MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics , 2016, Familial Cancer.

[7]  Kathryn J. Rowland,et al.  Management of the Parathyroid Glands During Preventive Thyroidectomy in Patients With Multiple Endocrine Neoplasia Type 2. , 2015, Annals of surgery.

[8]  I. B. Borel Rinkes,et al.  Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2 , 2015, Medicine.

[9]  Douglas B. Evans,et al.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[10]  H. Dralle,et al.  Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  G. Cevenini,et al.  Reference range of serum calcitonin in pediatric population. , 2015, The Journal of clinical endocrinology and metabolism.

[12]  J. Varhaug,et al.  Surgical Curability of Medullary Thyroid Cancer in Multiple Endocrine Neoplasia 2B: A Changing Perspective , 2014, Annals of surgery.

[13]  K. Lorenz,et al.  Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutations. , 2014, The Journal of clinical endocrinology and metabolism.

[14]  Kathryn J. Rowland,et al.  Pheochromocytoma in an 8‐year‐old patient with multiple endocrine neoplasia type 2A: Implications for screening , 2013, Journal of surgical oncology.

[15]  H. Dralle,et al.  Benefit-Risk Balance of Reoperation for Persistent Medullary Thyroid Cancer , 2013, Annals of surgery.

[16]  C. Sekulla,et al.  Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium. , 2013, European journal of endocrinology.

[17]  K. Lorenz,et al.  Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. , 2013, The Journal of clinical endocrinology and metabolism.

[18]  A. Pinchera,et al.  The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. , 2012, The Journal of clinical endocrinology and metabolism.

[19]  G. Valk,et al.  Unilateral Subtotal Adrenalectomy for Pheochromocytoma in Multiple Endocrine Neoplasia Type 2 Patients: A Feasible Surgical Strategy , 2011, Annals of surgery.

[20]  A. Tabarin,et al.  Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines. , 2011, The Journal of clinical endocrinology and metabolism.

[21]  C. Ugolini,et al.  RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) , 2011, Clinical endocrinology.

[22]  R. Kapur,et al.  Counting myenteric ganglion cells in histologic sections: an empirical approach. , 2010, Human pathology.

[23]  H. Dralle,et al.  Biomarker-based risk stratification for previously untreated medullary thyroid cancer. , 2010, The Journal of clinical endocrinology and metabolism.

[24]  T. Rich,et al.  Multiple endocrine syndrome type 2B in early childhood: Long-term benefit of prophylactic thyroidectomy (Cancer (2010) 116, (2284)) , 2010 .

[25]  M. Aroichane,et al.  Diffuse corneoscleral limbal neuromas with prominent corneal nerves in multiple endocrine neoplasia syndrome type IIB. , 2010, Journal of pediatric ophthalmology and strabismus.

[26]  A. Toniato,et al.  Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  J. Oates,et al.  Kindred with prominent corneal nerves associated with a mutation in codon 804 of RET on chromosome 10q11. , 2010, Archives of ophthalmology.

[28]  J. Hamming,et al.  UvA-DARE ( Digital Academic Repository ) Factors Predicting Outcome of Total Thyroidectomy in Young Patients with Multiple Endocrine Neoplasia Type 2 : A Nationwide Long-Term Follow-up Study , 2010 .

[29]  C. Allen,et al.  Multiple endocrine neoplasia-2B presenting with orthodontic relapse. , 2010, The Angle orthodontist.

[30]  W. Meier-Ruge,et al.  The histopathology of gastrointestinal motility disorders in children. , 2009, Seminars in pediatric surgery.

[31]  K. Lorenz,et al.  Individualization of Lymph Node Dissection in RET (Rearranged During Transfection) Carriers at Risk for Medullary Thyroid Cancer: Value of Pretherapeutic Calcitonin Levels , 2009, Annals of surgery.

[32]  Z. Şıklar,et al.  Early prophylactic thyroidectomy for RETmutation‐positive MEN 2B , 2009, Pediatrics international : official journal of the Japan Pediatric Society.

[33]  K. Lorenz,et al.  Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities , 2009, Journal of internal medicine.

[34]  J. Hugot,et al.  Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B. , 2009, European journal of endocrinology.

[35]  H. Dralle,et al.  The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT , 2009, European Radiology.

[36]  S. Hess,et al.  Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. , 2008, Surgery.

[37]  W. Foulkes,et al.  Inherited susceptibility to common cancers. , 2008, The New England journal of medicine.

[38]  S. Hauptmann,et al.  Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10. , 2008, Endocrine-related cancer.

[39]  S. Hauptmann,et al.  Prediction of lateral lymph node metastases in medullary thyroid cancer , 2008, The British journal of surgery.

[40]  M. Cohen,et al.  MEN 2B syndrome should be part of the working diagnosis of constipation of the newborn , 2008, Histopathology.

[41]  S. Bielack,et al.  Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report. , 2007, Journal of pediatric surgery.

[42]  S. Hauptmann,et al.  Increased Risk of Lymph Node Metastasis in Multifocal Hereditary and Sporadic Medullary Thyroid Cancer , 2007, World Journal of Surgery.

[43]  H. Dralle,et al.  Genotype-Phenotype Based Surgical Concept of Hereditary Medullary Thyroid Carcinoma , 2007, World Journal of Surgery.

[44]  Susan S. Taylor,et al.  RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B. , 2006, Cancer research.

[45]  H. Buhr,et al.  Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. , 2006, European journal of endocrinology.

[46]  M. Moorghen,et al.  Adult transmural intestinal ganglioneuromatosis is not always associated with multiple endocrine neoplasia or neurofibromatosis: a case report , 2006, Journal of Clinical Pathology.

[47]  K. Owzar,et al.  Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. , 2005, The New England journal of medicine.

[48]  H. Lehnert,et al.  Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. , 2005, The Journal of clinical endocrinology and metabolism.

[49]  J. Moley,et al.  Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: a report of two cases. , 2005, The Journal of clinical endocrinology and metabolism.

[50]  H. Holzhausen,et al.  Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. , 2005, The Journal of clinical endocrinology and metabolism.

[51]  C. Sekulla,et al.  Multiple Endocrine Neoplasia 2B Syndrome due to Codon 918 Mutation: Clinical Manifestation and Course in Early and Late Onset Disease , 2004, World Journal of Surgery.

[52]  B. Robinson,et al.  External ophthalmic findings in multiple endocrine neoplasia type 2B , 2004, Clinical & experimental ophthalmology.

[53]  H. Okinaga,et al.  RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[54]  H. Holzhausen,et al.  Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma , 2004, The British journal of surgery.

[55]  H. Dralle,et al.  Early malignant progression of hereditary medullary thyroid cancer. , 2003, The New England journal of medicine.

[56]  P. Beck‐Peccoz,et al.  Frequent association between MEN 2A and cutaneous lichen amyloidosis , 2003, Clinical endocrinology.

[57]  E. Baudin,et al.  Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. , 2003, The Journal of clinical endocrinology and metabolism.

[58]  J. Schipper,et al.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[59]  T. Lairmore,et al.  Gastrointestinal Manifestations of Multiple Endocrine Neoplasia Type 2 , 2002, Annals of surgery.

[60]  W. Foulkes,et al.  Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET , 2001, Journal of medical genetics.

[61]  V. Rohmer,et al.  Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients. , 2001, The Journal of clinical endocrinology and metabolism.

[62]  H. Dralle,et al.  Konjunktivale Neurome und prominente korneale Nervenfasern als diagnostischer Hinweis auf endokrinologische Multiorganerkrankungen , 2001 .

[63]  M. Wiench,et al.  Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  H. Dralle,et al.  Chemoembolization of Liver Metastases from Medullary Thyroid Carcinoma , 2000, Annals of Internal Medicine.

[65]  M. Ichihara,et al.  A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations. , 2000, Biochemical and biophysical research communications.

[66]  M. Bouvet,et al.  Surgical strategy for the treatment of medullary thyroid carcinoma. , 1999, Annals of surgery.

[67]  C. Eng,et al.  Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment , 1999, Gut.

[68]  W. Linehan,et al.  Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. , 1999, The New England journal of medicine.

[69]  J. Moley,et al.  Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. , 1999, Annals of surgery.

[70]  A. Miyauchi,et al.  Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation , 1999, Japanese journal of cancer research : Gann.

[71]  R. Hinze,et al.  Prophylactic Thyroidectomy in 75 Children and Adolescents with Hereditary Medullary Thyroid Carcinoma: German and Austrian Experience , 1998, World Journal of Surgery.

[72]  D. Ball,et al.  Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. , 1998, Annals of surgery.

[73]  M. Schlumberger,et al.  Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients , 1998 .

[74]  C. Eng,et al.  Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine. , 1998, The Journal of clinical endocrinology and metabolism.

[75]  L. Mulligan,et al.  Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. , 1997, The Journal of clinical endocrinology and metabolism.

[76]  B. Ponder,et al.  Germline mutation of RET codon 883 in two cases of de novo MEN 2B , 1997, Oncogene.

[77]  X. Matías-Guiu,et al.  Multiple idiopathic mucosal neuromas: a minor form of multiple endocrine neoplasia type 2B or a new entity? , 1997, Journal of the American Academy of Dermatology.

[78]  R. A. Decker,et al.  Prophylactic Surgery for Multiple Endocrine Neoplasia Type IIa after Genetic Diagnosis: Is Parathyroid Transplantation Indicated? , 1996, World Journal of Surgery.

[79]  M. Borrello,et al.  RET activation by germline MEN2A and MEN2B mutations. , 1995, Oncogene.

[80]  H. Gharib,et al.  Multiple endocrine neoplasia type 2B: more than an endocrine disorder. , 1995, Surgery.

[81]  C. Eng,et al.  No mutation at codon 918 of the RET gene in a family with multiple endocrine neoplasia type 2B , 1995, Clinical endocrinology.

[82]  B. Ponder,et al.  Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium , 1995, Journal of internal medicine.

[83]  H. Dralle,et al.  Primary hyperparathyroidism in multiple endocrine neoplasia type 2A , 1995, Journal of internal medicine.

[84]  H. Dralle,et al.  The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study , 1995, Journal of internal medicine.

[85]  T. van Vroonhoven,et al.  Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. , 1994, The New England journal of medicine.

[86]  J. Ivanovich,et al.  Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2A , 1994, Annals of surgery.

[87]  P. Goodfellow,et al.  Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. , 1993, Human molecular genetics.

[88]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[89]  S. Takai,et al.  Prominent corneal nerves in patients with multiple endocrine neoplasia type 2A: Diagnostic implications , 1992, World Journal of Surgery.

[90]  M. Draznin,et al.  Multiple endocrine syndrome type IIb in early childhood , 1991, Cancer.

[91]  M. Ikeda,et al.  Incidence of prominent corneal nerves in multiple endocrine neoplasia type 2A. , 1991, American journal of ophthalmology.

[92]  A H Tashjian,et al.  The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. , 1988, The New England journal of medicine.

[93]  H. Vasen,et al.  Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands. , 1987, The American journal of medicine.

[94]  J. Farndon,et al.  The Importance of Early Diagnosis in Patients with Hereditary Medullary Thyroid Carcinoma , 1982, Annals of surgery.

[95]  J. Carney,et al.  Multiple endocrine neoplasia with skeletal manifestations. , 1981, The Journal of bone and joint surgery. American volume.

[96]  P. Dyck,et al.  Multiple endocrine neoplasia, type 2b: Phenotype recognition; neurological features and their pathological basis , 1979, Annals of neurology.

[97]  V. Go,et al.  Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b. , 1976, The New England journal of medicine.

[98]  J. Carney,et al.  Mucosal ganglioneuromatosis, medullary thyroid carcinoma, and pheochromocytoma: multiple endocrine neoplasia, type 2b. , 1976, Oral surgery, oral medicine, and oral pathology.

[99]  O. Beahrs,et al.  Medullary carcinoma of the thyroid gland , 1975, Cancer.

[100]  R A Vickers,et al.  Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid—a syndrome , 1968, Cancer.

[101]  Hartmann Wh,et al.  Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. A possible regulatory defect in the differentiation of chromaffin tissue. , 1968 .

[102]  E. D. Williams,et al.  A review of 17 cases of carcinoma of the thyroid and phaeochromocytoma , 1965, Journal of clinical pathology.

[103]  L. W. Smith,et al.  MALIGNANT DISEASE OF THE THYROID GLAND , 1934 .

[104]  Dr. Curt Froboese.  Das aus markhaltigen Nervenfasern bestehende, ganglienzellenlose, echte Neurom in Rankenform , 1922, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[105]  E. Stoffel.  Lokales Amyloid der Schilddrüse , 1910, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[106]  J. Jaquet.  Ein Fall von metastasierenden Amyloidtumoren (Lymphosarkom) , 1906, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[107]  H. Dralle,et al.  Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium , 2018, The Journal of clinical endocrinology and metabolism.

[108]  F. Raue,et al.  [Multiple endocrine neoplasia]. , 2017, Deutsche medizinische Wochenschrift.

[109]  Douglas B. Evans,et al.  Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening , 2012, Annals of Surgical Oncology.

[110]  E. Rocha,et al.  Dry eye in childhood: epidemiological and clinical aspects. , 2008, The ocular surface.

[111]  Jeffrey E. Lee,et al.  Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think? , 2007, Annals of Surgical Oncology.

[112]  H. Holzhausen,et al.  Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: systemic disease? , 2006, Surgery.

[113]  E. Baudin,et al.  Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome , 2002, Cancer.

[114]  P. V. van Diest,et al.  Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. , 2002, The Journal of clinical endocrinology and metabolism.

[115]  R. Hinze,et al.  Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. , 2001, Surgery.

[116]  M. Schlumberger,et al.  Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[117]  L. Mulligan,et al.  Mutations of the RET proto‐oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease , 1997, Human mutation.

[118]  J. Norton,et al.  Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. , 1996, Journal of pediatric surgery.

[119]  H. Dralle,et al.  Surgical approach of synchronous medullary thyroid carcinoma and pheochromocytoma in MEN 2 syndrome. , 1992, Henry Ford Hospital medical journal.

[120]  H. Dralle,et al.  Surgical management of MEN 2. , 1992, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[121]  E. D. Williams,et al.  Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen's disease. , 1966, The Journal of pathology and bacteriology.